secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001213900-22-082358
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity gets Nasdaq extension to April 10, 2023 to meet $2.5M equity requirement
--------------------------------------------------------------------------------

- Nasdaq granted extension until April 10, 2023, to regain compliance with $10M equity rule.
- Company plan includes raising capital and moving to Nasdaq Capital Market ($2.5M equity).
- Previous notice of deficiency received October 12, 2022; plan submitted December 12, 2022.
- No assurance given that compliance will be achieved by the extended deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390022082358/0001213900-22-082358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390022082358/ea170792-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-082358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer